Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri)
ABSTRACT Background and Purpose: Natalizumab (NTZ) is widely used for patients with highly active relapsing–remitting multiple sclerosis (RRMS), but its discontinuation can lead to disease reactivation, significantly impacting Middle Eastern populations. This study aimed to assess the frequency of d...
محفوظ في:
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wiley
2025-09-01
|
| سلاسل: | Brain and Behavior |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1002/brb3.70904 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|